The Lynx Group


Evidence-based medicine and a focused clinical orientation are key elements to delivering the right care at the right time to the right person. The recent findings reported at the 2011 American Society of Clinical Oncology annual meeting regarding the use of novel therapies and strategies in the treatment of non–small-cell lung cancer make achieving these goals harder than ever.
Read Article

The management of complex oncology drugs in pharmacy and in medical benefits presents unique challenges for all parties who seek cost-effective, positive clinical outcomes for patients with cancer. New therapies are offering the exciting prospect of improved outcomes, prolonged life, and, in some cases, a cure for specific diseases.
Read Article

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to receive the free VBCC print publication or weekly e‑Newsletter.

I'd like to receive: